CD8A and non-small cell lung carcinoma: In this study, we evaluated serial blood samples from patients with resectable NSCLC undergoing standard neoadjuvant chemoimmunotherapy to characterize the evolution of peripheral immune cells, such as CD8 + T-cell and Treg subsets, and preliminarily described the possible mechanisms of different pathological responses in NSCLC patients.